Drug Information

Drug General Information
Drug ID
D0Y7UJ
Former ID
DNC009142
Drug Name
1-(2-(naphthalen-2-yl)ethyl)piperazine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530012]
Formula
C16H20N2
Canonical SMILES
C1CN(CCN1)CCC2=CC3=CC=CC=C3C=C2
InChI
1S/C16H20N2/c1-2-4-16-13-14(5-6-15(16)3-1)7-10-18-11-8-17-9-12-18/h1-6,13,17H,7-12H2
InChIKey
MXNHEKIHSVXJPG-UHFFFAOYSA-N
PubChem Compound ID
44592243
Target and Pathway
Target(s) Sodium-dependent serotonin transporter Target Info Inhibitor [530012]
KEGG Pathway Serotonergic synapse
NetPath Pathway TCR Signaling Pathway
PANTHER Pathway 5HT1 type receptor mediated signaling pathway
5HT2 type receptor mediated signaling pathway
5HT3 type receptor mediated signaling pathway
5HT4 type receptor mediated signaling pathway
WikiPathways Monoamine Transport
SIDS Susceptibility Pathways
NRF2 pathway
Synaptic Vesicle Pathway
Serotonin Transporter Activity
References
Ref 530012Bioorg Med Chem Lett. 2009 Apr 15;19(8):2329-32. Epub 2009 Feb 20.Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.
Ref 530012Bioorg Med Chem Lett. 2009 Apr 15;19(8):2329-32. Epub 2009 Feb 20.Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.